Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2026-01-26 00:00:00 ET · period of report 2026-01-26 · accession 0001628280-26-003468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-26 | 2026-01-26 | MDGL | Sibold William John | Pres, CEO, Dir | S - Sale | $492.42 | -1,577 | 148.5K | -1% | -$776.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-26 | S | D | 1,577 | $492.42 | 148,497 | D | — | — |